Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . December 27th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Antiviral Therapy - Lamivudine pulse therapy treats HBeAg-positive patients with normal ALT values
Chronic Hepatitis C - Regimented retreatment benefits a select group of hepatitis C non-responders
Diagnostics - Serum contains preneoplastic markers for hepatitis B virus-related liver cancer
Hepatitis C Virus Therapy - Combination therapy containing ribavirin generates HCV RNA mutagenesis
Immunology - Rising anti-hepatitis C virus titers reflect the evolution of acute disease
Artificial Liver Support - Extracorporeal albumin dialysis improves survival in acute liver failure
Bloodborne Pathogens - Unwise practices encourage hepatitis C transmission in Pakistan blood donors
Business Update - Perfusion-technology company reports activities during third-quarter 2004
Chronic Hepatitis B - Lamivudine clears hepatitis B virus surface antigen in young adults
Chronic Liver Disease - Hepatitis C may block apoptosis by modulating pro-apoptosis signals
Diagnostic Imaging - Compensated CT scans of hepatic portal perfusion portray liver disease status
Diagnostics - A new potentiometric sensor enhances hepatitis B surface antigen detection
Disease Associations - Hepatitis C virus infection may cause recurrent myelitis
Drug Metabolism - Adefovir phosphorylation and half life length predict anti-hepatitis B efficacy
Embryonic Stem Cell Research - Glycogen- and albumin-producing hepatocyte-like cells generated from ESCs
HIV/AIDS - Diagnostic kits producer receives order for Vscan HIV test kit
Hematology - Multiplex real-time quantitative RT-PCR screens donor blood for pathogens
Hepatitis - PEGASYS combination therapy eradicates hepatitis C in 50% of "healthy" carriers
Hepatitis A Virus - Apoptosis induced by hepatitis A virus dependent on caspase activation
Hepatitis C - Albuferon in combination with Ribavirin commences in hepatitis C study patients
Hepatitis C - HO9 initial results in hepatitis C presented at integrative oncology conference
Hepatitis C Virus - Experimental nonpharmacological treatment promising in reducing viral load
Hepatocellular Carcinoma - Percutaneous ethanol injection is effective therapy for liver cancer patients
Hepatology - Liver site-specific gene transfer generates protein in murine models
Mutagenesis - Concurrent gene and protein analyses expose p53 status in liver cancer patients
Personnel - Biopharmaceutical company names vice president business development
Personnel - Michael S. Weiss named nonexecutive director of biopharmacutical company
Psychology - Comprehensive treatment programs aid women with iatrogenic chronic hepatitis C
Transplant Medicine - Certican MRP expanded to include 10 new E.U. member states
Viral Genomics - Geographical differences sway the unique variations of hepatitis B subtypes
Viral Persistence - Circulating exosomes sustain the hepatitis C virus life cycle
Virology - Hepatitis C virus E2 protein interacts with CD81 to alter lymphocyte migration
Virology - Trak-C HCV core assay monitors antiviral activity in HCV replication systems
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
